Trump Ditches New Negotiating Powers For Medicare Part D

The Trump administration on Thursday abandoned extra leeway for Medicare Part D plans to negotiate prices for prescription drugs that treat serious diseases, dealing a setback to its blueprint for making...

Already a subscriber? Click here to view full article